Molecular detection approaches for smoking associated tumors

[1]  D. Sidransky,et al.  Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. , 2002, Cancer research.

[2]  R. Hurst,et al.  Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine. , 2001, Journal of the National Cancer Institute.

[3]  A. Nakao,et al.  Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  D. Sidransky,et al.  Cigarette smoking is strongly associated with mutation of the K‐ras gene in patients with primary adenocarcinoma of the lung , 2001, Cancer.

[5]  R. Weiss,et al.  Urine detection of survivin and diagnosis of bladder cancer. , 2001, JAMA.

[6]  A. Franchi,et al.  Prediction of recurrence by microsatellite analysis in head and neck cancer , 2000, Genes, chromosomes & cancer.

[7]  J. Jen,et al.  Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer. , 2000, Cancer research.

[8]  J. Jen,et al.  Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. , 2000, Science.

[9]  Quan-hong Wang,et al.  Identification of novel regions of allelic loss from a genomewide scan of esophageal squamous‐cell carcinoma in a high‐risk Chinese population , 2000, Genes, chromosomes & cancer.

[10]  J. Herman,et al.  Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. , 2000, Cancer research.

[11]  D. Sidransky,et al.  The potential of molecular screening. , 1999, Surgical oncology clinics of North America.

[12]  R. Weiss,et al.  Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. , 1999, The New England journal of medicine.

[13]  J. Jen,et al.  Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Carissa A. Sanchez,et al.  Evolution of neoplastic cell lineages in Barrett oesophagus , 1999, Nature Genetics.

[15]  J. Califano,et al.  Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin. , 1999, Journal of the National Cancer Institute.

[16]  J. Herman,et al.  Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. , 1999, Journal of the National Cancer Institute.

[17]  H. Miyake,et al.  Highly specific and sensitive detection of malignancy in urine samples from patients with urothelial cancer by CD44v8–10/CD44v10 competitive RT‐PCR , 1998, International journal of cancer.

[18]  O. Cussenot,et al.  Assessment of microsatellite instability in urine in the detection of transitional‐cell carcinoma of the bladder , 1998, International journal of cancer.

[19]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[20]  Jack A. Taylor,et al.  The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. , 1998, Cancer research.

[21]  R Doll,et al.  Uncovering the effects of smoking: historical perspective , 1998, Statistical methods in medical research.

[22]  H. Saya,et al.  Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs. , 1998, Journal of the National Cancer Institute.

[23]  D. Sidransky,et al.  Nucleic acid-based methods for the detection of cancer. , 1997, Science.

[24]  David Sidransky,et al.  Detection of bladder cancer recurrence by microsatellite analysis of urine , 1997, Nature Medicine.

[25]  D. Sugarbaker,et al.  Screening for Lung Cancer: Another Look; A Different View , 1997 .

[26]  David Sidransky,et al.  Microsatellite alterations in serum DNA of head and neck cancer patients , 1996, Nature Medicine.

[27]  A. Kurt,et al.  Microsatellite alterations in plasma DNA of small cell lung cancer patients , 1996, Nature Medicine.

[28]  Y S Erozan,et al.  Molecular Detection of Primary Bladder Cancer by Microsatellite Analysis , 1996, Science.

[29]  Z. Ronai,et al.  High frequency of K‐ras mutations in normal appearing lung tissues and sputum of patients with lung cancer , 1995, International journal of cancer.

[30]  W. Rom,et al.  Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. , 1995, Journal of the National Cancer Institute.

[31]  R H Hruban,et al.  Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. , 1995, The New England journal of medicine.

[32]  K. Rieger,et al.  Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors. , 1995, Journal of the National Cancer Institute.

[33]  D. Sidransky,et al.  Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. , 1994, American journal of surgery.

[34]  Y S Erozan,et al.  Microsatellite alterations as clonal markers for the detection of human cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Hruban,et al.  Allelotype of head and neck squamous cell carcinoma. , 1994, Cancer research.

[36]  J. Ferlay,et al.  Estimates of the worldwide incidence of eighteen major cancers in 1985 , 1993, International journal of cancer.

[37]  S. Lippman,et al.  Head and Neck Cancer , 1993, Cancer Treatment and Research.

[38]  L. Freedman,et al.  The future of prognostic factors in outcome prediction for patients with cancer , 1992, Cancer.

[39]  D. Carbone.  Smoking and cancer. , 1992, The American journal of medicine.

[40]  T. Pechacek,et al.  Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States? , 1991, Journal of the National Cancer Institute.

[41]  P. Green,et al.  Identification of p53 gene mutations in bladder cancers and urine samples. , 1991, Science.

[42]  A. Miller,et al.  Risk of bladder cancer by source and type of tobacco exposure: A case‐control study , 1989, International journal of cancer.

[43]  D. Hémon,et al.  Tobacco and bladder cancer in males: Increased risk for inhalers and smokers of black tobacco , 1989, International journal of cancer.

[44]  R. Tsuchiya,et al.  Prognosis and survival in resected lung carcinoma based on the new international staging system. , 1988, The Journal of thoracic and cardiovascular surgery.

[45]  M. Melamed,et al.  The National Cancer Institute Cooperative Early Lung Cancer Detection Program. Results of the initial screen (prevalence). Early lung cancer detection: Introduction. , 1984, The American review of respiratory disease.

[46]  A. Morrison,et al.  An international study of smoking and bladder cancer. , 1984, The Journal of urology.

[47]  W M Murphy,et al.  Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms , 1984, Cancer.

[48]  T. Davidson,et al.  Microscopic Controlled Excisions for Epidermoid Carcinoma of the Head and Neck , 1981, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[49]  Taylor Murray,et al.  Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.

[50]  J. Herman,et al.  Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. , 1999, Cancer research.

[51]  Taylor Murray,et al.  Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.